Breadcrumb

What’s new at The Institute?

First patient in Canada receives mRNA-based bladder cancer treatment in clinical trial at the MUHC

The investigational therapy combines mRNA technology with immunotherapy...

D2R awards $10 million to accelerate RNA-based therapies for rare diseases and cancer

Three members of The Institute are among recipients of D2R funding to support their groundbreaking...

Researchers honoured with King Charles III's Coronation Medal for outstanding achievements

In recognition of their contributions to the understanding of neurological and respiratory disease, four members...

Inaugural Research Canada Innovates event at The Institute a resounding success

Sold-out event united health researchers and innovators to shape the future of healthcare

Experts from the McGill International TB Centre and The Institute publish a prestigious Lancet seminar on TB

Commissioned work underscores the role of tuberculosis (TB) as a leading...

Final winners announced in inaugural Networks competition

Three interdisciplinary teams awarded funding to launch innovative research networks at The Institute

New funding for cystic fibrosis research

Larry Lands, a senior scientist at The Institute, will lead a new project focusing on rare genetic mutations

Addressing health disparities through genomics

Researcher from The Institute co-leads $8.3 million genomics sequencing project to advance for Black communities

Learn more about the RI-MUHC